Company Profile
GRI Bio Stock Price, News & Analysis
- Ticker:
- GRI
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, GRI Bio is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
1.86 USD (-0.53%)
Close
Last updated: June 23, 2026 at 00:00
3.29M USD
Market cap
Why the stock is moving
GRI is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
GRI Bio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, GRI Bio is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
GRI Bio follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, GRI Bio sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
GRI Bio to Present at the 2024 European Respiratory Congress
Source: GRI Bio
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of GRI Bio (GRI)?
GRI Bio (GRI) most recently closed at 1.86 USD, a -0.53% move versus the previous session.
What is the market cap of GRI Bio (GRI)?
GRI Bio currently has a market capitalization of 3.29M USD on BioPharmSignal.
What does GRI Bio do?
GRI Bio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is GRI stock listed?
GRI Bio (GRI) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, GRI Bio is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Which conditions is GRI Bio targeting with Investors?
GRI Bio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.